Creating Outstanding Pharmaceutical Companies
Accelerated Drug Approval
Orphan Drug Approval
Unapproved to Approved
Central Nervous System
Ricanto creates outstanding pharmaceutical companies acquiring the rights to undervalued, under-recognized or challenging pharmaceutical assets. Ricanto companies are focused on excellence, cost-effectiveness, meeting unmet medical needs and patient outcomes.
With a track record of success and superior returns to its investors/shareholders, Ricanto provides operational and financial capital to derisk and optimize companies prior to commercialization.